National Bank Of Canada Karuna Therapeutics, Inc. Transaction History

National Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$164.66 - $218.08 $2,963 - $3,925	18 Added 16.36%	128 $21,000
Q2 2023 Jul 26, 2023	BUY	$176.32 - $240.22 $1,763 - $2,402	10 Added 10.0%	110 $23,000
Q1 2023 Apr 12, 2023	SELL	$161.33 - $204.36 $161 - $204	-1 Reduced 0.99%	100 $18,000
Q4 2022 Jan 24, 2023	BUY	$191.53 - $236.82 $19,344 - $23,918	101 New	101 $0

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.